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Alcohol use disorder (AUD) is a chronic and relapsing disease with a substantial genetic influence. 
Given the recent discovery of the association of PPM1G methylation with alcohol use disorder (AUD) 
from a genome-wide methylation study, we sought to verify and extend the previous work of AUD-
related impulsivity in a Korean population with AUD. A total of 244 men with AUD were assessed for 
psychological characteristics and behavioral impulsivity using stop signal task (response inhibition) and 
Balloon Analog Risk Task (risk-taking). Leukocyte DNA methylation at PPM1G was quantified using 
pyrosequencing. The effects of PPM1G methylation on severity of problematic drinking measured by 
Alcohol Use Disorder Identification Test (AUDIT) and multidimensional impulsivity were tested using 
linear regression analyses. Hypermethylation of PPM1G was significantly associated with risk-taking 
propensity among men with AUD. No significant association of PPM1G methylation was found to be 
associated with AUDIT scores and response inhibition. Our findings indicate that altered methylation of 
PPM1G may influence the impulsive choice of risk-taking in AUD. Further research is required in order to 
determine the role of PPM1G in the pathophysiology of AUD and multidimensional impulsivity.
Alcohol use disorder (AUD) is a chronic relapsing disease characterized by excessive alcohol drinking and loss of 
control over alcohol consumption. Approximately 50% of the risk of AUD can be attributed to genetic factors1. 
Based on the results from genome-wide association studies of AUD, it is suggested that hundreds of variants 
with small genetic effects across the genome contribute to the genetic susceptibility of AUD2. In addition to a 
genetic predisposition, growing evidence supports the theory that environmental factors, such as early life stress, 
increases vulnerability for the development and psychopathological conditions of AUD3,4. Childhood adversity 
has been reported to be associated with early initiation of alcohol5 and higher suicidal attempts in patients with 
AUD6. These findings suggest that the interplay between genes and environment is involved in the pathophysi-
ology of AUD.
Epigenetic modifications such as DNA methylation (reversible modulation of gene expression without chang-
ing the DNA sequence), can be key to understanding these gene-environment interactions. A genome-wide DNA 
methylation study with 18 monozygotic twin pairs discordant for AUD discovered a differentially methylated 
region in the 3’-protein-phosphatase-1G (PPM1G) gene that is considered to be potentially involved in modulat-
ing cortical transmission to the striatum through dephosphorylation of the metabotropic glutamate receptors7. 
That study also showed that the PPM1G DNA methylation level was associated with PPM1G gene expression, and 
PPM1G hypermethylation was correlated with an escalation in daily alcohol drinking as well as an impulsivity 
trait, measured by self-reported impulsivity and brain activity during behavioral inhibition task, in independent 
adolescent samples7.
Given the recent discovery of an epigenetic association of the PPM1G gene with AUD, we sought to verify 
and extend the previous work of AUD-related impulsivity in a Korean clinical population with AUD. Since the 
impulsivity trait, an endophenotype for AUD, is a multifaceted construct8,9, we assessed multidimensional impul-
sivity using a self-report measure and behavioral tasks, including impulsive action of response inhibition and 
impulsive choice of risk-taking, and examined their associations with the PPM1G. To ascertain an unbiased effect 
of the PPM1G, we controlled for the effects of potential confounders such as childhood adversity on epigenetic 
modulation.
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Methods
Participants. A total of 244 male subjects with AUD were included in this study. All participants were 
recruited from inpatients psychiatric facilities for detoxification and rehabilitation of AUD and assessed after 
detoxification treatment. Diagnosis of AUD was confirmed by psychiatrists using a structured clinical interview 
for the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV-TR) criteria and clinical 
observation. Most recent drinking confirmed by clinician was at least 7 days before study enrollment, and no signs 
of alcohol intoxication or withdrawal symptoms were observed in any participant on the study day of self-report 
questionnaire and tasks. Exclusion criteria were: (1) being admitted primarily for another major psychiatric disor-
der; (2) having an intellectual disability; and (3) having other substance dependencies except tobacco use. In addi-
tion, subjects with mood disorders including major depressive disorder based on the DSM-IV-TR criteria and 
clinician’s careful observation were excluded. Participants were ethnically all Korean. Ethnicity was determined 
based on self-reported ethnicity and the administrator’s observations. All patients who participated in this study 
provided written informed consent according to the procedures approved by the Severance Hospital Institutional 
Review Board (Seoul, Korea), and all protocols were performed in accordance with approved guidelines.
Measurements. The severity of problematic drinking in patients with AUD was assessed using the Alcohol 
Use Disorders Identification Test (AUDIT)10. Higher AUDIT scores indicated a more harmful drinking behavior. 
The Korean version of the Barratt Impulsiveness Scale (BIS) was also used to assess participants’ self-reported 
impulsivity. To evaluate childhood trauma, we used the modified Korean version of the Parent-Child Conflict 
Tactics Scale (mPCCTS)11 which is based on the Parent-Child Conflict Tactics Scale12. The severity of depressive 
and anxiety symptoms was assessed using the Beck Depression Inventory (BDI)13 and the Beck Anxiety Inventory 
(BAI)14. All questionnaires had been validated in the Korean population previously11,15–18.
Behavioral tasks for impulsive action and impulsive choice. The stop signal task (SST) was used to 
assess the impulsive action of response inhibition19. The stop-signal reaction time (SSRT) was estimated. A higher 
SSRT value indicates a worse inhibitory control. In addition, the Balloon Analog Risk Task (BART)20, a comput-
erized decision-making test, was conducted to assess the impulsive choice of risk-taking. Risk-taking propensity 
was measured by calculating the mean number of pumps in trials during which the balloons did not explode, a 
higher BART score represents a greater risk-taking propensity.
Pyrosequencing of PPM1G. Venous blood samples were collected in 4 ml EDTA vacutainers and stored 
at −80 °C prior to analysis. Genomic DNA was isolated from whole blood using the standard techniques. Three 
cytosine-guanine (CpG) sites in the 3’ untranslated region (UTR) of PPM1G were selected and designed using 
PSQ Assay Design software (QiagenTM) based on the previous study7. The genomic locations of the three selected 
CpG sites were as follows: CpG1 (Chr2: 27,604,246; GRCh37), CpG2 (Chr2: 27,604,258; GRCh37), and CpG3 
(Chr2: 27,604,271; GRCh37). Pyrosequencing was used for DNA methylation analysis by Genomictree, Inc. The 
DNA was bisulfite treated and sequencing was performed using the Pyro Gold reagents kit (Qiagen, Hilden, 
Germany).
Statistical analyses. The SPSS 25.0 software for Windows (SPSS Inc., Chicago, IL, USA) was used for anal-
yses of all data in this study. Descriptive statistical analyses were performed for various variables including demo-
graphic, clinical, and epigenetic characteristics of the participants in this study. Multivariable linear regression 
analyses with the ‘enter method’ were used to test the associations of the PPM1G methylation level with the 
AUDIT scores and multidimensional impulsivity (self-reported impulsivity; BIS score, impulsive action; SST, 
and impulsive choice; BART) after adjusting for multiple potential confounders. The regression model included 
the PPM1G methylation level, childhood trauma (high vs. low), and other demographic and clinical variables 
(age, duration of AUD, depressive symptoms, and anxiety levels), that may influence the relationship between the 
PPM1G and AUD-related phenotypes, as independent variables. Childhood trauma exposure was categorized as 
a binary value, high and low, using a median split of mPCCTS scores. The mean value of methylation levels at the 
three CpG sites in PPM1G was used for analyses.
Results
Demographic and clinical characteristics. Socio-demographic, clinical characteristics and the methyla-
tion level of the PPM1G of the study participants are summarized in Table 1. All participants were men with AUD, 
and further detailed descriptions are presented in Table 1.
Regression model predicting the severity of problematic drinking and multidimensional impul-
sivity. A regression model demonstrated no significant association of the PPM1G with AUDIT scores. Among 
the potential associated factors selected as independent variables by the regression model, young age, long dura-
tion of AUD, higher BDI scores and presence of childhood adversity were significantly associated with higher 
AUDIT scores (Table S1).
For multidimensional impulsivity, a regression model of impulsive action showed a significant associa-
tion between PPM1G and risk-taking propensity as measured by the BART (Table 2). In this model, PPM1G 
methylation explained 3.5% of the variance in risk-taking propensity, indicating small to moderate effect size. 
Hypermethylation of the PPM1G was correlated with higher risk-taking propensity. On the other hand, a regres-
sion model of the BIS score showed no significant association of the PPM1G with self-reported impulsivity trait. 
In that model, only depressive symptom severity was significantly associated with self-reported impulsivity 
(Table S2). In addition, a regression model of impulsive choice showed no significant association of the PPM1G 
with response inhibition by SSRT value (Table S3).
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Discussion
The present study examined the role of PPM1G DNA methylation in multidimensional impulsivity among 
clinical samples with AUD, based on the novel finding of the PPM1G differentially methylated region from a 
genome-wide DNA methylation study of monozygotic twins discordant for AUD7. Our results demonstrated 
a significant association between PPM1G hypermethylation and the impulsive choice of risk-taking propensity 
after adjusting for the possible effects of variable confounders such as childhood adversity on epigenetic changes. 
When considering that the impulsive choice of risk-taking dramatically increases in early adolescence21 and is 
known to contribute to increase susceptibility for AUD22, our findings suggest that PPM1G hypermethylation 
may mediate the effect of high risk-taking in the pathophysiology of AUD.
Hypermethylation at the PPM1G region on chromosome 2 has been reported to be associated with lower 
mRNA levels of PPM1G in adolescent non-clinical samples7, although we did not examine the mRNA expression 
in this study. The previous finding indicates that PPM1G methylation levels influence PPM1G expression and pro-
tein levels. PPM1G is a member of the human protein phosphatase 2C (PP2C) family which has been implicated 
in cellular survival and stress response23,24. Studies in animals and in vitro work suggested a role of the PPM1G in 
regulating cell cycle progression and cellular stress response pathways23. Although little is known about the bio-
logical functioning of the PPM1G in humans, there is some indirect evidence suggesting a relationship between 
the PPM1G and AUD-related phenotypes. The region of chromosome 2p14‐2q14.3 has been linked to various 
psychiatric conditions including AUD and suicidal attempts, related to impulsivity and behavioral disinhibi-
tion25–27. A genetic study with polymorphisms across chromosome 2 in a case-control sample for alcoholism 
showed a significant association of rs2384629, a genetic polymorphism on the PPM1G gene, with combined AUD 
and suicide attempts or conduct phenotypes25. This suggests a genetic role of the PPM1G in AUD-related impul-
sivity. Ruggeri et al. reported a significant association of PPM1G hypermethylation with self-reported impulsivity 
measured by impulsivity-related subscales of the Substance Use Risk Profile Scale (SURP). This association was 
significant even after controlling for the possible genotype effects of polymorphisms covering the PPM1G locus 
of methylation status. Although the biological function of the PPM1G remained unclear, these findings suggest 
Variable aAUD (n = 244)
Age, years 45.87 ± 6.68
Duration of AUD, years 16.03 ± 9.33
Clinical characteristics
AUDIT 27.13 ± 7.55
BDI 18.09 ± 12.41
BAI 13.50 ± 11.01
mPCCTS 2.89 ± 3.30
Multidimensional impulsivity trait
BIS 51.03 ± 10.49
bSSRT 173.38 ± 136.53
BART 28.53 ± 15.36
PPM1G methylation (%)
CpG1 89.54 ± 3.06 c(82.17, 99.92)
CpG2 96.44 ± 3.03 c(85.28, 100)
CpG3 94.48 ± 1.03 c(87.05, 97.99)
Table 1. Demographic, clinical, psychological characteristics and PPM1G methylation status of patients with 
AUD. AUD, alcohol use disorder; AUDIT, the Alcohol Use Disorders Identification Test; BDI, Beck. Depression 
Inventory; BAI, Beck Anxiety Inventory; BIS, Barratt Impulsiveness Scale; mPCCTS, modified Parent-Child 
Conflict Tactics Scale; SSRT, Stop Signal Reaction Time. BART, Balloon Analog Risk Task. aMean ± standard 
deviation; bN = 221; c(Minimum, Maximum).
B SE β T P
Constant −142.712 63.758 −2.238 0.026
Age −0.296 0.162 −0.129 −1.821 0.07
Duration of AUD −0.07 0.117 −0.043 −0.599 0.55
BDI −0.005 0.1 −0.004 −0.046 0.963
BAI −0.028 0.112 −0.02 −0.255 0.799
bEarly life trauma −0.315 2.04 −0.01 −0.154 0.877
cPPM1G methylation (%) 1.999 0.677 0.187 2.954 0.003
Table 2. Multiple linear regression analysisa with enter method for predicting the risk-taking propensity 
(BART) in patients with AUD (N = 244). aModel summary: R2 = 0.059, adjusted R2 = 0.035, F(6, 237) = 2.464, 
P = 0.025. bHigh early life trauma was coded as 1, low early life trauma was coded as 0 based on the median 
value of mPCCTS. cMean value of methylation at three CpG sites in PPM1G. BART, Balloon Analog Risk Task; 
AUD, alcohol use disorder; SE, Standard error; BDI, Beck Depression Inventory; BAI, Beck Anxiety Inventory.
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that the PPM1G may play a role in the pathophysiology of AUD, possibly through the impulsivity trait, an endo-
phenotype for AUD.
Among our regression models predicting severity of problematic drinking or multidimensional impulsiv-
ity, the PPM1G methylation level was significant only for the impulsive choice of risk-taking, not for AUDIT 
scores, self-reported impulsivity, or impulsive action of behavioral inhibition using the stop signal task. Lack 
of significant association between PPM1G and AUDIT scores in the present study seemed to be consistent with 
the previous negative finding of alcohol exposure severity in non-clinical adolescents7. However, our sample 
consisted entirely of chronic alcohol-dependent patients with relatively high AUDIT scores. Therefore, the rela-
tionship between PPM1G methylation and severity of AUD needs to be confirmed in a cohort that includes the 
entire spectrum of AUDIT scores. For impulsivity, there was some discrepancy of self-reported impulsivity and 
behavioral inhibition between our study and Ruggeri’s results. However, direct comparison may be difficult due 
to a variety of differences including demographic factors such as age, sex, and ethnicity, clinical characteristics 
(e.g. clinical vs. non-clinical), measurements of impulsive action and choice, as well as the used self-report tools 
(e.g. BIS vs. SURP). Because impulsivity is a complex and multidimensional construct in nature8,9, comprehensive 
measure of multidimensional impulsivity would be beneficial to enhance the determination of the genetic effects 
on trait impulsivity and brain response related to impulsivity as an endophenotype for AUD.
Although biological mechanisms modulating methylation status of PPM1G is unknown, recent research sug-
gests that excessive alcohol use can induce epigenetic dysregulation in human and rodent brains through alter-
ation of the DNA methylation dynamics such as changes in DNA-methyltransferase (DNMT) expression and 
activity28,29. A postmortem brain study of bipolar disorder and schizophrenia suggested that chronic alcohol 
abuse has an effect on number of DNMT 1 mRNA-positive neurons29. Further research is needed to elucidate the 
biological mechanisms underlying regulation of DNA methylation of PPM1G.
There are several limitations to this study. First, we did not recruit healthy controls, as our main purpose 
was to examine epigenetic influence of PPM1G on quantitative AUD-related traits such as impulsivity among 
individuals with AUD. Future case control studies with healthy controls may help understand disease-specific 
methylation changes of PPM1G and their role in AUD. In addition, when considering sex differences in alcohol 
use and alcohol-related problems30, our findings in male patients may have limited application to female patients 
with AUD. Second, our study with a cross-sectional design restricts the ability to reveal a causal link of PPM1G 
methylation with the AUD-related impulsivity trait. Ruggeri et al.’s finding of a significant association of PPM1G 
hypermethylation with the escalation of daily alcohol drinking between ages 14 and 16 in non-clinical adoles-
cents supports the possibility that PPM1G hypermethylation may be a vulnerable marker for developing AUD, 
rather than a consequence of AUD. Future longitudinal research is warranted in order to establish the direction 
of causality in their relationship. Third, we did not consider the effect of some potential confounders, including 
heterogeneity in white blood cell composition31 and cigarette smoking32,33, that may contribute to inter-individual 
variability in DNA methylation. In particular, since smoking can induce epigenetic modifications, the possible 
effect of smoking on DNA methylation should be considered in future studies. Fourth, since we cannot measure 
DNA methylation levels directly in the brain during clinical studies, we assumed that the DNA methylation 
pattern of PPM1G in peripheral leukocytes reflects the PPM1G methylation pattern in brain. Although DNA 
methylation is tissue-specific, there is some evidence suggesting that patterns of peripheral DNA methylation 
or mRNA expression reflect changes in brain tissues34,35. In addition, peripheral PPM1G methylation levels have 
been reported to be associated with brain activity during the impulsive action task of the SST7. However, it is still 
questionable whether peripheral DNA methylation could serve as surrogates for DNA methylation in the brain. 
Finally, the present sample size may be limited to detect an association between DNA methylation levels at a given 
CpG site and a complex phenotype controlled by many genes with very small effect. Therefore, a study with a 
larger number of samples with stronger statistical power is needed to confirm the present findings.
In summary, the present study illustrated that the hypermethylation of PPM1G was significantly associated 
with the impulsive choice of risk-taking propensity, not the severity of problematic alcohol drinking, in a male 
Korean clinical population with AUD. The present finding supports the conclusion that the altered methylation 
status of PPM1G influences the pathophysiology of AUD, possibly through the impulsivity trait of risk-taking. 
Further prospective research is required in order to determine the role of PPM1G in the pathophysiology of AUD 
and multidimensional impulsivity.
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